AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic
Open Access
- 14 February 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 13 (1), 1-4
- https://doi.org/10.1038/s41467-022-28529-9
Abstract
The COVID-19 pandemic has driven demand for integrated genomics, resulting in fast-tracked development of AusTrakka, Australia’s pathogen genomics platform. This facilitated rapid data sharing, democratised access to computational and bioinformatic resources and expertise, and achieved national real-time genomic surveillance. The COVID-19 pandemic has accelerated the demand for near real-time analysis and dissemination of pathogen genomic data. In this comment, the authors describe how Australia has developed and rolled out its SARS-CoV-2 genomics platform, AusTrakka, and used it to support public health action.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council (GNT1196103)
- Medical Research Future Fund (MRFF), Australia
This publication has 7 references indexed in Scilit:
- Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological studyThe Lancet Public Health, 2021
- Tracking the COVID-19 pandemic in Australia using genomicsNature Communications, 2020
- Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern CaliforniaScience, 2020
- Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modelingNature Medicine, 2020
- The Transformation of Reference Microbiology Methods and Surveillance for Salmonella With the Use of Whole Genome Sequencing in England and WalesFrontiers in Public Health, 2019
- Precision epidemiology for infectious disease controlNature Medicine, 2019
- Practical Value of Food Pathogen Traceability through Building a Whole-Genome Sequencing Network and DatabaseJournal of Clinical Microbiology, 2016